Abstract
Measles virus infection as well as measles vaccination induces a long-lasting immune protection. Specific antibodies have been proven to be associated with this immune protection, since measles immunity can be transferred by immune globulin application (passive immunisation). The neutralisation test (NT) is regarded as the gold standard method for measles immunity because it measures functional neutralising antibody, while with the ELISA, which is often based on cell culture grown native virus antigens, predominantly antibodies to the nucleoprotein antigen were detected. To compare the results of NT and ELISA 199 individual sera and 364 gamma globulin samples, which were made from plasma pools, were tested. Qualitative results showed that the sensitivity of the ELISA was 141/144 (97.9%) and specificity was 48/55 (87.3%) when compared to the NT and focused to the patient samples. For the gamma globulin samples the sensitivity and specificity was 100%. As expected no measles NT negative plasma pool samples were found. The present study showed that with increasing NT-titre, the ELISA-values also rise. False negative ELISA results were obtained in 1.5% of patient sera, mainly containing low levels of neutralising antibody. In both antibody tests seropositive specimens revealed a quite good to moderate correlation. Taken together, the measles IgG ELISA is adequately for immunity testing and identifying of seronegative individuals for vaccination.
Similar content being viewed by others
References
Cohen BJ, Parry RP, Doblas D, Samuel D, Warrener L, Andrews N, Brown D (2006) Measles immunity testing: comparison of two measles IgG ELlSAs with plaque reduction neutralisation assay. J Virol Methods 131:209–212
Cronin M, O’Connell T (2000) Measles outbreak in Republic of Ireland. http://www.eurosurveillance.org/ew/2000100060 1.asp
Griffin DE (2001) Measles virus. In: Knipe DM, Howley PM (eds) Measles virus in fields virology. Lippincott, Williams & Wilkins, Philadelphia, pp 1401–1441
Hesketh L, Charlett A, Farrington P, Miller E, Forsey T, Morgan-Capner P (1997) An evaluation of nine commercial EIA kits for the detection of measles specific IgG. J Virol Methods 66:51–59
Lee MS, Nokes DJ, Hsu HM, Lu CF (2000) Protective titres of measles neutralising antibody. J Med Virol 62:511–517
Markowitz LE, Katz SL (1994) Measles vaccine. In: Plotkin SA, Mortimer EA Jr (eds) Vaccines, 2nd edn. Saunders, Philadelphia, pp 229–76
Min-Shi L, Cohen BJ, Hand J, Nokes D (1999) A simplified and standardised neutralization enzyme immunoassay for the quantification of measles neutralizing antibody. J Virol Methods 78:209–217
Neumann PW, Weber JM, Jessamine AG, O’Shaughnessy MV (1985) Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay and hemagglutination inhibition test with neutralization test for determination of immune status. J Clin Microbiol 22(2):296–298
Rabenau HF, Weber B (1994) Evaluation of a new automated microneutralization assay for the quantitative detection of neutralizing antibodies against enteroviruses. Zbl Bakt Int J Med Microbiol 280:534–539
Schmitz H, Essuman S (1986) Comparison of the neutralizing and ELISA antibody titres to human cytomegalovirus (HCMV) in human sera and in gamma globulin preparations. J Med Virol 20(2):177–182
Siedler A, Leitmeyer K (2004) Relevance of sentinel surveillance systems for the implementation and evaluation of vaccination strategies. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47:1136–1143
van den Hof S, van Gageldonk-Lafeber AB, van Binnendijk RS, van Gageldonk PG, Berbers GA (2003) Comparison of measles virus-specific antibody titres as measured by enzyme-linked immunosorbent assay and virus neutralisation assay. Vaccine 21:4210–4214
World Health Organisation (2005) Measles fact sheet. http://www.who.int/mediacentre/factsheets/fs286/en
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rabenau, H.F., Marianov, B., Wicker, S. et al. Comparison of the neutralizing and ELISA antibody titres to measles virus in human sera and in gamma globulin preparations. Med Microbiol Immunol 196, 151–155 (2007). https://doi.org/10.1007/s00430-007-0037-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00430-007-0037-2